What is Selenium?
Selenium is a mineral used for corrects selenium deficiency and supports the activity of selenoproteins (glutathione peroxidases, thioredoxin reductases) that defend cells against oxidative stress.. NutriDex grades the human evidence as Mixed. Selenium is an essential trace mineral incorporated as selenocysteine into selenoproteins such as glutathione peroxidases and thioredoxin reductases, which give it antioxidant activity and a role in thyroid hormone metabolism and immune function. Correcting a genuine deficiency clearly benefits health, and in autoimmune (Hashimoto) thyroiditis, 6 months of supplementation modestly reduces TPO antibodies and TSH, with moderate-certainty evidence but no proven change in long-term disease course. However, supplementing people who are already replete shows little benefit: the large SELECT randomized trial (35,533 men) found selenium did not prevent prostate cancer and produced a non-significant increase in type 2 diabetes risk. A Cochrane review concluded selenium does not prevent cancer and that supplementation increased diabetes risk by roughly 11% in trials. Selenium has an unusually narrow safe range — the gap between the recommended 55 mcg/day and the 400 mcg/day upper limit is small, and chronic excess causes selenosis (hair and nail loss, garlic breath, neurological effects). Overall the evidence is mixed: valuable for deficiency and possibly thyroid autoimmunity, but unhelpful or potentially harmful when status is already adequate.
Purported Benefits
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| TPO antibodies & TSH in Hashimoto thyroiditis6 months lowers TPOAb/TSH (moderate certainty) in those not on thyroid hormone; disease-modifying benefit unproven. | Moderate | ↑ benefit · small | 3 |
| Prostate / cancer prevention in replete menSELECT RCT (n=35,533) and Cochrane found no cancer prevention in already-replete people. | Strong | — no effect · negligible | 2 |
| Type 2 diabetes riskCochrane (+11%) and NPC trial (HR 1.55, dose-dependent) signal increased diabetes risk with supplementation in replete people. | Moderate | ⚠ risk · small | 3 |
| Correcting deficiency / selenoprotein activityClear benefit limited to correcting genuine deficiency; narrow safe range (RDA 55 vs UL 400 mcg). | Strong | ↑ benefit · moderate | 1 |
Dosing & Compounds
Safety & Cautions
Selenium drug interactions
Known or theoretical interactions between Selenium and common medications — educational, not exhaustive. Always check with your doctor or pharmacist before combining Selenium with any medicine.